19-12799911-A-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005809.6(PRDX2):āc.459T>Gā(p.Asp153Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000577 in 1,613,818 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005809.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDX2 | NM_005809.6 | c.459T>G | p.Asp153Glu | missense_variant | 5/6 | ENST00000301522.3 | NP_005800.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDX2 | ENST00000301522.3 | c.459T>G | p.Asp153Glu | missense_variant | 5/6 | 1 | NM_005809.6 | ENSP00000301522.2 |
Frequencies
GnomAD3 genomes AF: 0.000592 AC: 90AN: 152142Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000545 AC: 137AN: 251400Hom.: 0 AF XY: 0.000559 AC XY: 76AN XY: 135888
GnomAD4 exome AF: 0.000575 AC: 841AN: 1461558Hom.: 1 Cov.: 31 AF XY: 0.000579 AC XY: 421AN XY: 727076
GnomAD4 genome AF: 0.000591 AC: 90AN: 152260Hom.: 0 Cov.: 31 AF XY: 0.000564 AC XY: 42AN XY: 74446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 12, 2024 | The c.459T>G (p.D153E) alteration is located in exon 5 (coding exon 4) of the PRDX2 gene. This alteration results from a T to G substitution at nucleotide position 459, causing the aspartic acid (D) at amino acid position 153 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at